Skip to main content

MoneyWorks4Me

Lupin informs about press release

08 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) Multiple-Dose Vials, on receipt of U.S. FDA approval to the Company’s alliance partner Caplin Steriles for its ANDA. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1889.95
Dr. Reddys Labs. 1389.70
Cipla 1413.15
Lupin 1996.25
Zydus Lifesciences 1199.85
View more..